Department of Neurology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Neuroscience Center, Samsung Medical Center, Seoul, Republic of Korea.
Cerebellum. 2023 Jun;22(3):386-393. doi: 10.1007/s12311-022-01416-1. Epub 2022 May 28.
The effect of transcranial direct current stimulation (tDCS) for cerebellar-dominant multiple-system atrophy (MSA-C) is not well elucidated, yet. This study aimed to investigate the effect of tDCS on the primary motor cortex (M1) and cerebellum in patients with MSA-C. We recruited probable MSA-C patients and performed three single sessions of tDCS at each visit in random order (M1, cerebellum or sham). Cerebellar ataxia was evaluated with the International Cooperative Ataxia Rating Scale (ICARS) and objective gait and static balance analyses both before and after each stimulation session. Additionally, we also evaluated the factors related with objective improvement from each stimulation. Sixteen participants were enrolled, and one dropped out after 2 sessions of stimulation due to consent withdrawal. The gait velocity, step time and single support time all significantly improved after the M1 and cerebellar tDCS treatment compared with the sham stimulation while there was no difference in the improvement of ICARS and posturography results among 3 stimulations. In terms of the related factors with improvement of gait velocity, the disease duration, baseline gait speed and single support times were correlated after M1 stimulation, while a higher ICARS score and baseline gait speed in cerebellar stimulation. There were no adverse effects reported after the tDCS sessions. Our results demonstrated that both M1 and cerebellar tDCS demonstrated benefits for MSA-C patients without significant complications. Considering the different related factors with improvement at each stimulation, the mechanism would be different between M1 and cerebellar stimulations.
经颅直流电刺激(tDCS)对以小脑为主的多系统萎缩(MSA-C)的影响尚未阐明。本研究旨在探讨 tDCS 对 MSA-C 患者大脑运动皮层(M1)和小脑的影响。我们招募了可能的 MSA-C 患者,并在每次就诊时以随机顺序(M1、小脑或假刺激)进行三次单疗程 tDCS。采用国际合作共济失调评定量表(ICARS)评估小脑共济失调,在每次刺激前后进行客观步态和静态平衡分析。此外,我们还评估了与每次刺激的客观改善相关的因素。共纳入 16 名参与者,1 名参与者在 2 次刺激后因退出研究而脱落。与假刺激相比,M1 和小脑 tDCS 治疗后步态速度、步时和单腿支撑时间均显著改善,而 3 种刺激方式对 ICARS 和平衡测试结果的改善无差异。在与步态速度改善相关的因素方面,M1 刺激后疾病持续时间、基线步态速度和单腿支撑时间与改善相关,而小脑刺激后 ICARS 评分和基线步态速度与改善相关。tDCS 治疗后无不良反应报告。我们的结果表明,M1 和小脑 tDCS 均对 MSA-C 患者有益,且无明显并发症。考虑到每次刺激改善的相关因素不同,M1 和小脑刺激的机制可能不同。